Atrion Corporation (ATRI) Raises Dividend to $1.20 Per Share
Atrion Corporation (NASDAQ:ATRI) declared a quarterly dividend on Tuesday, August 15th, RTT News reports. Shareholders of record on Friday, September 15th will be paid a dividend of 1.20 per share by the medical instruments supplier on Friday, September 29th. This represents a $4.80 dividend on an annualized basis and a yield of 0.77%. This is a boost from Atrion Corporation’s previous quarterly dividend of $1.05.
Atrion Corporation has raised its dividend by an average of 17.6% annually over the last three years and has raised its dividend every year for the last 14 years.
Shares of Atrion Corporation (NASDAQ ATRI) traded down 0.73% on Tuesday, reaching $625.05. The company’s stock had a trading volume of 2,147 shares. The firm’s 50 day moving average is $639.83 and its 200-day moving average is $540.28. Atrion Corporation has a 52-week low of $393.95 and a 52-week high of $691.95. The stock has a market cap of $1.16 billion, a P/E ratio of 35.02 and a beta of 0.91.
Atrion Corporation (NASDAQ:ATRI) last released its earnings results on Tuesday, August 8th. The medical instruments supplier reported $5.40 earnings per share (EPS) for the quarter. Atrion Corporation had a return on equity of 18.67% and a net margin of 22.75%. The business had revenue of $36.16 million during the quarter. On average, equities research analysts forecast that Atrion Corporation will post $9.90 EPS for the current year.
Separately, BidaskClub downgraded Atrion Corporation from a “strong-buy” rating to a “buy” rating in a research report on Thursday, July 27th.
In other Atrion Corporation news, Chairman Emile A. Battat sold 100 shares of the firm’s stock in a transaction on Friday, June 9th. The stock was sold at an average price of $585.50, for a total value of $58,550.00. Following the completion of the sale, the chairman now directly owns 149,081 shares of the company’s stock, valued at $87,286,925.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Chairman Emile A. Battat sold 699 shares of the firm’s stock in a transaction on Tuesday, June 6th. The stock was sold at an average price of $580.84, for a total value of $406,007.16. Following the completion of the sale, the chairman now directly owns 149,480 shares of the company’s stock, valued at $86,823,963.20. The disclosure for this sale can be found here. Insiders sold 3,392 shares of company stock valued at $1,900,070 over the last three months. Company insiders own 24.23% of the company’s stock.
About Atrion Corporation
Atrion Corporation (Atrion) is engaged in developing and manufacturing products, primarily for medical applications. The Company’s medical products range from fluid delivery devices to ophthalmic and cardiovascular products. Its fluid delivery products include valves that promote infection control and needle safety.
Receive News & Ratings for Atrion Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atrion Corporation and related companies with MarketBeat.com's FREE daily email newsletter.